EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
European Lead Factory
Head of European Screening Centre
Ton Rijnders is the Head of Screening at the European Lead Factory He holds a PhD in molecular biology and has an extensive experience with drug discovery in pharma with increasing managerial and scientific responsibilities Since November Ton is the General Director of Oncode Institute and has been involved since the very beginning in European Lead Factory via the partner Lygature
Articles
The Growing Role of Biocatalysis in Industrial Synthesis
Since the late th century chemical catalysis has been a cornerstone of organic synthesis and pharmaceutical manufacturing driving the development and mass production of key therapeutic molecules across multiple disease areas Despite its broad adoption and long history traditional organic synthesis techniques remain constrained by several unavoidable drawbacks
Research Insights
Spectrophotometric And Spectroscopic Studies On Charge Transfer Complexes Of Antifungal Drug Clotrimazole
Abstract Clotrimazole CLZ is an imidazole derivative which is therapeutically used as an antifungal drug The routine control analysis of CLZ requires rapid reliable accurate and precise methods for the quantification of drug in its pharmaceutical formulations Spectrophotometric methods are presented for the determination of antifungal agent which were bas
Case Studies
Heat Stable Hepatitis B vaccine
Partner Since Arecor has collaborated with PATH an international global health nonprofit organisation on the development of heat stable vaccines using the ArestatT technology Stabilisation of hepatitis B vaccine one of the many vaccines successfully st
Techno Trends
Genentech Unveils First and Only Susvimo® for the Treatment of Diabetic Macular Oedema
Genentech has introduced Susvimo ranibizumab injection mgmL as the first continuous drug delivery system for adults with diabetic macular oedema DME a leading cause of vision loss in people with diabetes
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Revolutionising Tuberculosis Treatment test
Adjunct Professor, Tampere University
Researcher, SVKM's Institute of Pharmacy
Use of Steroids in COVID-19 patients
Assistant Professor, Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University
Viksit Bharat@ 2047 envisioned the Indian Pharma Industry
Academician
Passionate educator, Dr L H Hiranandani College of Pharmacy
press releasesRead more...
Sun Pharma signs Definitive Agreement to Acquire Organon
Sun Pharmaceutical Industries Limited Reuters SUNBO Bloomberg SUNP IN NSE SUNPHARMA BSE together with its subsidiaries andor associated companies Sun Pharma and Organon Co
Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg
Thermo Fisher Scientific Inc NYSE TMO the world leader in serving science today announced that it has signed a definitive agreement to sell its microbiology business to Astorg a leading panEuropean private equity firm
IMG Pharma Enters into Definitive Agreement to Acquire Matsumoto Pharmaceutical
IMG Pharmaceutical Co Ltd IMG Pharma a majorityowned subsidiary of IMG Japan the Groups holding company announced that it has entered into a definitive agreement to acquire Matsumoto Pharmaceutical Co Ltd a Japanese pharmaceutical manufacturer
Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with Cardiomyopathy
Prothena Corporation plc today announced that the US Food and Drug Administration FDA has granted Fast Track Designation to coramitug a potential bestinclass amyloid depleter antibody currently in Phase development
Xcovery Partners with EVERSANA to Commercialize Lung Cancer Drug Ensacove in the U.S.
Xcovery Holdings Inc Xcovery an evidencebased innovationdriven pharmaceutical company today announced an agreement with EVERSANA a leading provider of commercialization services to the global life sciences industry
Mabwell Initiates Phase III Clinical Study of its Nectin-4-Targeting ADC 9MW2821 for the Treatment of Triple-Negative Breast Cancer
Mabwell an innovationdriven biopharmaceutical company with a fully integrated industry chain announces the initiation of a Phase III clinical study of its proprietary Nectintargeting ADC for the treatment of triplenegative breast cancer
EventsRead more...
29 - 30
Apr 2026Pharma Partnering US Summit 2026
Hilton San Diego, USA
05 - 06
May 2026GENAP Summit 2026
Vienna, Austria
06 - 07
May 202641th pharmacovigilance USA 2026
Boston, USA
06 - 07
May 20262nd Edition MaxPotent Pharma Summit 2026
Milan, Italy
07 - 08
May 202621st PPM for Pharma & Biotech
New Jersey, USA
10 - 14
May 2026Respiratory Drug Delivery 2026
The Westin Kierland Phoenix, Arizona, USA
12 - 13
May 2026PDA Pharmaceutical Manufacturing 2026
Singapore
14 - 14
May 2026PDA Microbiology in CCS Workshop 2026
Singapore
LATEST NEWSRead more...
Lilly to Acquire Ajax Therapeutics to Advance Treatments for Myelofibrosis and Polycythaemia Vera
Eli Lilly and Company has entered into a definitive agreement to acquire Ajax Therapeutics Ajaxs lead candidate AJ is an investigational oncedaily oral Type II JAK inhibitor It is currently being evaluated in a Phase clinical trial
Terns Pharmaceuticals Receives Breakthrough Therapy for TERN-701 in Chronic Myeloid Leukemia (CML)
Terns Pharmaceuticals has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation BTD to TERN an investigational oral allosteric BCRABL inhibitor
Cipla Secures US FDA Approval for First AB-Rated Generic of Ventolin HFA
Cipla and its subsidiary Cipla USA have received final approval from the US Food and Drug Administration FDA for their Abbreviated New Drug Application ANDA for Albuterol Sulfate Inhalation Aerosol mcg per actuation The product is the first ABrated generic equivalent of Ventolin HFA originally mark...
AbbVie to Invest $1.4 Billion in New Manufacturing Campus in North Carolina
AbbVie has announced plans to invest billion in the development of a pharmaceutical manufacturing campus in Durham North Carolina The acre site will incorporate advanced manufacturing systems
Leinco Technologies and CellCarta Partner to Strengthen Proteomics Solutions for Drug Development
Leinco Technologies a specialist in antibody and protein development has entered into a strategic collaboration with CellCarta a global provider of precision medicine laboratory services to advance proteomics
New combination therapy for advanced small cell lung cancer approved in Australia and Singapore
Independent biopharmaceutical company Specialised Therapeutics has secured approval for ZEPZELCA lurbinectedin in combination with atezolizumab as a firstline maintenance treatment for adults with extensivestage